n-Ethyl-6-methylpyridazin-3-amine, 97%, 50mg

RuCl(p-cymene)[(R,R)-Ts-DPEN], 98%, 5g

Tert-butyl(4s)-4-[(E)-3-bromoprop-1-enyl]-2,2-dimethyl-oxazolidine-3-carboxylate, 97% mix TBC as stabilizer, 100mg

(R)-PYRROLIDINE-3-CARBONITRILE HCL, 95.0%, 100mg

Vinyl But-2-enoate, 97.0%, 25ml

Nateglinide>98.0%(HPLC)(T)5g

Potassium 2,6-dibromo-4-((3,5-dibromo-4-oxocyclohexa-2,5-dien-1-ylidene)(2-(ethoxycarbonyl)phenyl)methyl)phenolate, 97%, 1g

2-Aminopyridine N-Oxide>98.0%(GC)(T)100mg

Ethyl 5-amino-1,2,4-oxadiazole-3-carboxylate, 95.0%, 1g

tert-Butyl (4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate, 95%, 1g

(S)-1-(5-Methylfuran-2-yl)propan-1-amine, 95.0%, 1g

(R)-3,3-Dimethylbutan-2-amine hydrochloride, 95.0%, 250mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 500mg